FindTrial
Sign In

A registry of antiplatelet therapy decisions in acute ischemic stroke within 72 hours of onset

A registry of antiplatelet therapy decisions in acute ischemic stroke within 72 hours of onset

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113409
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

24-48Hours After Onset Group:None

Sponsors

Affiliated Hospital of Jinggangshan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Acute ischemic stroke confirmed by head MRI, attributed to atherosclerosis; (2) Time interval from last known normal state to hospital visit within 72 hours; (3) Written informed consent signed by the patient or their family member.

Exclusion criteria

Exclusion criteria: (1) Intracranial hemorrhage confirmed by CT or MRI; (2) Received thrombolytic therapy or thrombectomy; (3) Confirmed cardiogenic embolic stroke or other etiologies causing stroke (including aortic dissection, cervico-cerebral artery dissection, vasculitis, vascular malformation, moyamoya disease/syndrome, fibromuscular dysplasia, etc.); (4) Expected inability to complete follow-up.

Design outcomes

Primary

MeasureTime frame
90-day mRS score;—

Secondary

MeasureTime frame
NIHSS score;—

Countries

China

Contacts

Public ContactYongcheng Zhang

Affiliated Hospital of Jinggangshan University

2378666511@qq.com+86 139 7065 6839

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026